Reasons to Watch: AbbVie Inc., The E. W. Scripps Company (NYSE:SSP), Corcept Therapeutics Incorporated (NASDAQ:CORT), Yamana Gold (NYSE:AUY)

Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) shares fell -7.20% in last trading session and ended the day at $3.74. SGYP has a return on assets of -66.80%. Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) quarterly performance is -40.63%.

On 11 January, Synergy Pharmaceuticals, Inc. (NASDAQ:SGYP) announced positive phase 1b data with its second uroguanylin analog, dolcanatide, in a double-blind, placebo-controlled, four-week study evaluating 28 patients with mild-to-moderate ulcerative colitis. Analysis of the data indicates clear signals of improvement in dolcanatide-treated patients compared with placebo-treated patients. Dolcanatide was also safe and well tolerated.

AbbVie Inc. (NYSE:ABBV) ended the last trading day at $54.99. Company weekly volatility is calculated as 7.32% and price to cash ratio as 9.72. AbbVie Inc. (NYSE:ABBV) showed a weekly performance of 3.13%.

AbbVie Inc. (NYSE:ABBV) said that, it took part in the company’s recently held corporate responsibility program “Week of Possibilities” and got together to restructure the exercise area of the Child’s Ability Center in Riyadh.

On 19 January, The E. W. Scripps Company (NYSE:SSP) shares fell -2.50% and was closed at $17.91. SSP EPS growth in last 5 year was 15.40%. The E. W. Scripps Company (NYSE:SSP) year to date (YTD) performance is -5.74%.

Zacks Investment Research upgraded shares of E. W. Scripps Co (NYSE:SSP) from a hold rating to a buy rating in a research note issued to investors on Tuesday, ARN reports. Zacks Investment Research currently has $22.00 price target on the stock.

Corcept Therapeutics Incorporated (NASDAQ:CORT) shares fell -1.67% in last trading session and ended the day at $3.53. CORT Gross Margin is 97.10% and its has a return on assets of -24.90%. Corcept Therapeutics Incorporated (NASDAQ:CORT) quarterly performance is -9.72%.

Piper Jaffray reiterated their buy rating on shares of Corcept Therapeutics Incorporated (NASDAQ:CORT) in a research note released on Tuesday, MarketBeatreports.

Yamana Gold, Inc. (NYSE:AUY) caters to the Basic Materials space. It has a net profit margin of -87.20% and weekly performance is -24.60%. On the last day of trading company shares ended up at $1.41. Yamana Gold, Inc. (NYSE:AUY) distance from 50-day simple moving average (SMA50) is -26.86%. ‘

On 13 January, Yamana Gold, Inc. (NYSE:AUY) provides full year preliminary production and cost estimates for 2015, as well as 2016, 2017 and 2018 production, and 2016 cost guidance.